Skip to main content
ACS Omega logoLink to ACS Omega
. 2026 Feb 7;11(7):12810–12823. doi: 10.1021/acsomega.5c11345

Selective Reversal of Cu-Amyloid Aggregation Monitored in Real Time by Fluorescence Anisotropy: Ni-Bme-Dach vs EDTA Benchmarks

Alyssa N Schroeder , Eleanor K Adams , Dane C Frost , Erica Lopez , Jennie R Giacomini , Marilyn R Mackiewicz †,*
PMCID: PMC12947006  PMID: 41768703

Abstract

Metal dyshomeostasis, particularly involving Cu2+, is increasingly recognized as a key contributor to amyloid-β (Aβ) aggregation and neurotoxicity in Alzheimer’s disease, motivating the development of chelators capable of selectively disrupting pathogenic metal-Aβ interactions without perturbing essential biological metals. Here, we employ steady-state fluorescence anisotropy as a real-time probe of TAMRA-Aβ1–42 rotational mobility to quantify metal-induced aggregation and its reversibility by two chelators with distinct selectivities: EDTA, a broad-spectrum benchmark, and Ni-bme-dach, a sulfur-rich metallodithiolate with high Cu affinity. Cu2+ induces the most significant increases in anisotropy, consistent with rapid formation of large nanoscale aggregates, while Fe3+ produces moderate aggregation and Zn2+ has minimal effect across pH 6.5 and 8.0. EDTA fully reverses Cu2+-induced aggregation but does so nonselectively, accompanied by pronounced fluorescence hyper-recovery indicative of broad metal stripping and fluorophore-environment perturbation. In contrast, Ni-bme-dach selectively extracts Cu2+, restoring monomer-like anisotropy at both pH values without hyper-recovery. UV–vis spectroscopy confirms formation of a discrete [Cu2-(Ni-bme-dach)3] complex, while TEM and AFM corroborate anisotropy trends and reveal a clear hierarchy of chelation responsiveness: Cu (fully reversible) > Fe (partially reversible) ≫ Zn (negligible). Together, these results establish fluorescence anisotropy as a sensitive kinetic platform for benchmarking chelator selectivity and demonstrate that Cu-driven Aβ aggregation is uniquely and selectively reversible. This work highlights metal-specific reversibility as a critical design principle for next-generation, Cu-targeted chelation strategies in Alzheimer’s disease.


graphic file with name ao5c11345_0011.jpg


graphic file with name ao5c11345_0009.jpg

Introduction

Alzheimer’s disease (AD) remains without effective disease-modifying therapies, despite decades of effort to target amyloid-β (Aβ) production, fibrillization, or clearance. A growing consensus recognizes that metal dysregulation, particularly involving Cu2+, Fe3+/Fe2+, and Zn2+, constitutes a central but underexploited therapeutic axis in AD. Elevated Cu and Zn concentrations (tens to hundreds of micromolar) have been reported in amyloid plaques and peri-plaque regions, where they accelerate Aβ aggregation, alter oligomer structure, promote oxidative stress, and amplify neurotoxicity. ,− While Cu2+ is especially pathogenic, both CuI/II or FeIII/II can undergo redox cycling in the presence of a reducing agent, generating reactive oxygen species (ROS) that impair synaptic signaling and lead to neuronal death.

Chelation studies linking metal homeostasis to Aβ1–42 aggregation and oxidative damage suggest that redissolving Aβ deposits may improve clinical outcomes in patients with AD. Consequently, there is intense interest in metal-modulating therapeutics, including Fe and Cu-binding ligands such as clioquinol, PBT2, and deferiprone. While these agents demonstrate some ability to redistribute metals and attenuate Aβ toxicity, ,, they often share a fundamental limitation: they are broad-spectrum chelators or have high affinities for multiple metals. For example, ethylenediamine tetraacetic acid (EDTA) (Scheme ) has a high affinity for Cu, Zn, and Fe without discrimination, complicating mechanistic interpretation and risking disruption of metal-dependent neurobiology, including Zn-regulated synaptic function and Fe-dependent metabolic pathways. , This lack of selectivity has hindered the development of therapeutics that precisely target pathogenic metal-Aβ interactions without destabilizing essential metalloprotein systems.

1. Chelator Ligands for Metal Sequestration.

1

Another critical challenge is that the distinct aggregation pathways induced by Cu2+, Fe3+, and Zn2+, and their reversibility, remain poorly defined. Classical amyloid assays, such as Thioflavin T and Congo Red, primarily detect β-sheet-rich fibrils and do not report on early oligomers or subtle conformational changes induced by metal binding. Consequently, it is unknown whether all metal-induced Aβ aggregates are equally accessible to chelation, or whether specific metals create reversible vs irreversible aggregation trajectories. Establishing this distinction is fundamental for designing selective chelators that disrupt only pathogenic metalated-Aβ species. To overcome these limitations, sensitive, real-time methods are needed to monitor metal-induced aggregation at low peptide concentrations. Fluorescence anisotropy provides this capability: by reporting peptide rotational mobility and hydrodynamic radius with nanosecond resolution, it can distinguish among monomers, small oligomers, and large supramolecular assemblies, an ability not afforded by intensity-only or fibril-specific assays. Fluorescence anisotropy has previously been applied to monitor Aβ aggregation using long-lifetime transition-metal probes, particularly Ru2+ complexes, , and its physical basis is well established for amyloid-binding organic dyes such as Thioflavin T and Congo Red, whose binding-induced rotational restriction underlies changes in fluorescence polarization. Such studies demonstrated that rotational constraints increase upon oligomer formation and that excited-state lifetimes strongly influence the accessible correlation-time regime. Fluorophore labeled-Aβ1–42 is particularly advantageous, as the fluorophore preserves native metal binding while sensitively reporting structural changes. N-terminal TAMRA labeling provides a convenient optical handle while preserving the metal-binding domain of Aβ. Studies of Aβ1–42 peptides conjugated to TAMRA at the N-terminal aspartate residue have shown that this labeling does not disrupt intrinsic aggregation pathways or metal-binding behavior. While minor interactions between TAMRA and the nearby Tyr10 residue have been shown to modulate fluorescence. The label remains sufficiently distant from key coordination residues and effectively tracks metal-induced conformational transitions, oligomerization, and aggregation. Still, as with any fluorophore modification, subtle effects on aggregation behavior are possible, and interpretation of TAMRA-based readouts is within this context. Building on this foundation, the present work used anisotropy not as a standalone sizing tool but as part of an integrated platform that directly compared how Cu2+, Fe3+, and Zn2+ induced nanoscale aggregates respond to broad-spectrum versus Cu-selective chelation. When combined with UV–vis spectroscopy and nanoscale imaging (transmission electron microscopy) (TEM) and atomic force microscopy (AFM), this platform offers a comprehensive, multilength-scale view of metal-specific aggregation and chelation response.

Within a therapeutic context, selective Cu extraction represents a compelling strategy for neutralizing pathogenic Cu–Aβ complexes while avoiding the biological costs associated with broad metal removal. Metallodithiolate ligands such as nickel-N,N′-bis-2-mercaptoethyl-N,N′-diazacycloheptane (Ni-bme-dach) (Scheme ) embody this approach. Inspired by N2S2 motifs in metalloenzymes such as acetyl-CoA synthase, Ni-bme-dach offers a biologically inspired alternative with inherent selectivity for soft, thiophilic metal centers, particularly Cu+/Cu2+. The N2S2 motif closely mimics metal-binding sites in enzymes such as acetyl-CoA synthase, and its sulfur-rich donor set preferentially stabilizes Cu over harder Lewis-acidic metals like Fe3+ or over biologically abundant cations such as Ca2+ and Mg2+. , Formation constants further emphasize these distinctions: EDTA exhibits log K values of 19.9 for Cu2+ and 16.4 for Zn2+, whereas Ni-bme-dach forms even stronger complexes with Cu (log K > 30) but much weaker complexes with Zn (log K ≈ 2). These thermodynamic preferences indicate that Ni-bme-dach is well positioned to selectively extract Cu2+ from metalated Aβ1–42 while avoiding essential metals and minimizing off-target chelation. Consequently, Ni-bme-dach is expected to outperform EDTA as a selective and mechanistically precise capture agent capable of reversing Cu-mediated Aβ aggregation without perturbing normal metal homeostasis.

Herein, this study investigates how Cu2+, Fe3+, and Zn2+ differentially trigger Aβ1–42 aggregation and whether the resulting assemblies are structurally and mechanistically reversible. Experiments were conducted at pH 6.5 and 8.0 to model mildly acidic endosomal and near-physiological extracellular conditions commonly used in metal-Aβ studies. The novelty lies in a direct comparison between a broad-spectrum chelator (EDTA) and a Cu-selective metallodithiolate (Ni-bme-dach) using an integrated platform of fluorescence anisotropy, fluorescence intensity, UV–vis spectroscopy, TEM, and AFM. This approach addresses key questions: Which metals drive distinct aggregation pathways? Are these aggregates equally susceptible to chelation-driven disassembly? Can Ni-bme-dach selectively extract Cu compared to EDTA’s nonselective behavior? How do nanoscale morphological changes correlate with real-time optical signatures of metal binding and aggregation? By focusing on early-stage, metal-induced Aβ1–42 aggregation under controlled in vitro conditions, this work establishes a mechanistic framework for evaluating metal-specific aggregation and chelation. Integrated analyses reveal a clear hierarchy of chelation response: complete reversibility for Cu-induced aggregates, partial for Fe, and minimal for Zn, a level of detail not previously mapped. Unlike fibril-binding dyes such as ThT, steady-state fluorescence anisotropy using TAMRA-Aβ1–42 reports real-time changes in hydrodynamic radius, enabling detection of early stage, metal-specific oligomerization events that precede β-sheet formation.

Experimental Procedure

Materials

Hexafluoroisopropanol (HFIP) and EDTA were purchased from Sigma-Aldrich. Sodium phosphate monobasic monohydrate, sodium phosphate dibasic heptahydrate, and copper sulfate were from BDH Chemicals. Ferrous chloride and ferric chloride were from Fisher Scientific, while zinc bromide was from Matheson Coleman and Bell. 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) was from OmniPur. The metallodithiolate (NiN2S2) complex, Ni-bme-dach, was prepared according to published procedures and was provided by Marcetta Y. Darensbourg of Texas A&M University. TAMRA-labeled-Aβ1–42 was purchased from CPC Scientific as a lyophilized powder and stored at −20 °C in HFIP. TAMRA-Aβ1–42 was prepared with a trifluoroacetate counterion and modified at the N-terminal end of the aspartic amino acid residue of the Aβ1–42 sequence: Asp–Ala–Glu–Phe–Arg–His–Asp–Ser–Gly–Tyr–Glu–Val–His–His–Gln–Lys–Leu–Val–Phe–Phe–Ala–Glu–Asp–Val–Gly–Ser–Asn–Lys–Gly–Ala–Ile–Ile–Gly–Leu–Met–Val–Gly–Gly–Val–Val–Ile-Ala – OH. All reagents were used as received. All experiments employed 100% TAMRA-labeled Aβ1–42, with no unlabeled peptide added.

Preparation of TAMRA-Aβ1–42

A 0.05 mg of lyophilized TAMRA-Aβ1–42 was suspended in 500 μL anhydrous HFIP and sonicated for 1 min to disperse any initial aggregates, then further diluted with an additional 500 μL HFIP. HFIP is a fluorinated alcohol that is miscible with water and well-suited for dissolving aggregation-prone peptides. The concentration of this solution was determined with UV–vis using the absorbance of the TAMRA dye at 545 nm and molar absorptivity of 90,000 cm–1 M–1. Stock solutions were stored in 200 mL aliquots at −20 °C to minimize freeze–thaw cycles of the initial stock. For all subsequent studies, stocks were diluted with HFIP to a final concentration of 5.52 μM before use and were stored at −20 °C.

Metal Binding, Aggregation, and Chelation Studies with TAMRA-Aβ1–42

For studies using TAMRA-Aβ1–42, fluorescence intensity and anisotropy data were collected at multiple time points and pH values. For metal-binding and chelation studies with EDTA, 10 mL of 5.52 μM TAMRA-Aβ1–42 was added to 1000 μL of 10 mM HEPES buffer at pH 6.5 or 8.0, yielding a final concentration of 55 nM. This is followed by the addition of 2 μL of 33 mM of CuSO4, FeCl3, or ZnBr2 in DI water, a 10 min incubation period, and stirring before data collection. Lastly, EDTA (5 μL of 0.5 M in DI water) was incubated with the metalated-TAMRA-Aβ1–42 sample for 5 min prior to data collection. For studies using the Ni-bme-dach, 20 mL of 5.52 μM TAMRA-Aβ1–42 was added to 1000 μL of 10 mM HEPES buffer at pH 6.5 or 8.0, yielding a final concentration of 110 nM. This is followed by the addition of 1 μL of 33 mM CuSO4, FeCl3, or ZnBr2 in DI water, with a 10 min incubation period and stirring. Lastly, Ni-bme-dach (20 μL of 0.018 M in DI water) was incubated with the metalated-TAMRA-Aβ1–42 sample for 5 min before data collection. Fluorescence intensity counts and anisotropy data were recorded at each sequential step of metal ion or chelator additions to the TAMRA-Aβ1–42 described above. Triplicate studies were performed, and data were expressed as means and standard deviations. Sample preparation was the same for the UV–vis metal binding and chelation studies with Ni-bme-dach and EDTA. Control samples with TAMRA-Aβ1–42 only, Ni-bme-dach or EDTA with each metal species, and metal ions only were compared at similar concentrations described here.

Fluorescence and UV–Vis Spectroscopy

Fluorescence measurements were performed on a HORIBA Fluorolog-QM PTI spectrophotometer using Felix32 software. Fluorescence intensity and anisotropy were measured using a 1.0 cm path length quartz cell with an excitation wavelength of 545 nm and an emission range of 550–650 nm. For fluorescence anisotropy measurements, emission was collected at 600 nm with a slith width of 6 nm. This wavelength was selected because it is near the λmax of TAMRA emission; however, it was shifted to reduce interference from scattering. A SCHOTT Colored Glass Longpass Filter with a cut-on wavelength of 570 nm was placed in the sample compartment in front of the emission detector to filter out wavelengths below 570 nm and ensure that polarized light from the excitation monochromator did not reach the detector. All anisotropy measurements were collected in steady-state mode. Because time-resolved anisotropy decays were not acquired, rotational correlation times and hydrodynamic radii are not extracted from these data. Instead, anisotropy is used as a relative indicator of changes in rotational mobility accompanying aggregation or chelation. The steady-state anisotropy (r) was derived from eq

r=IVVGIVHIVV+2GIVH 1

where I VV and I VH are the fluorescence intensities, the subscripts indicate the orientation of the excitation and emission polarizers, and G = I HV/I HH is the wavelength-dependent sensitivity of the instrument. Reported delta anisotropy (Δr) values are the average of three independent samples; each averaged over 60 s unless otherwise stated. There was a 10 min incubation period after the addition of the metal and chelator before data were collected. For anisotropy studies, Absorbance measurements were obtained using an Agilent Technologies Cary 5000 UV–Vis–NIR Spectrophotometer with a 1.0 cm path length quartz cuvette. These measurements capture early stage aggregation behavior, as metal-treated samples were incubated for approximately 10 min at room temperature.

TEM Studies of Aβ-Aggregation in the Presence and Absence of Metal Ions and Chelators

The following samples were prepared for TEM imaging: TAMRA-Aβ1–42 only, TAMRA-Aβ1–42 in the presence of metal ions, and TAMRA-Aβ1–42 in the presence of metal ions and EDTA or Ni-bme-dach. Briefly, 10 μL of 5.52 μM TAMRA-Aβ1–42 in HFIP was added to 100 μL of 10 mM PB (pH 8.0) to yield a final concentration of 0.55 mM, which was then deposited onto a TEM grid. For metal-binding studies, 2 μL of 33 mM CuSO4, FeCl3 or ZnBr2 in H2O was added to 10 μL of 5.52 μM TAMRA-Aβ1–42 in HFIP diluted with 100 μL of 10 mM PB pH 8.0 followed by incubation for 10 min before deposition onto a TEM grid. For chelation studies, the metal-TAMRA-Aβ1–42 sample, as described above, was incubated with 5 μL of 0.5 M EDTA in H2O for 10 min before deposition onto a TEM grid. For studies with Ni-bme-dach, samples were prepared similarly for deposition except with 20 μL of 5.52 μM Aβ1–42 in 100 μL of 10 mM PB pH 8.0 to yield a final concentration of 1.1 mM, with additions of freshly prepared 1 μL of 33 mM CuSO4, FeCl3, or ZnBr2, and 20 μL 0.018 M Ni-bme-dach in H2O. Each sample was drop-cast onto carbon-coated (300 Å) Formvar films on copper grids (Ted Pella) and air-dried overnight before imaging. Samples were stained with 2% uranyl acetate, and images were obtained of the samples after they were dried overnight. TEM imaging was acquired on a Tecnai F-20 FEI microscope using a CCD detector at an acceleration voltage of 200 kV.

AFM Studies of Aβ-Aggregation in the Presence and Absence of Metal Ions and Chelators

The following samples were prepared for AFM imaging: TAMRA-Aβ1–42 only, TAMRA-Aβ1–42 in the presence of metal ions, and TAMRA-Aβ1–42 in the presence of metal ions and EDTA or Ni-bme-dach. Briefly, 10 μL of 10.3 μM TAMRA-Aβ1–42 was dried into a film in an Eppendorf vial to remove HFIP, resuspended in 100 μL of 10 mM PB, pH 8.0, and sonicated for 30 s to disperse any aggregates formed during drying. For the TAMRA-Aβ1–42-only sample, 5 μL of a 103 nM solution in 10 mM PB (pH 8.0) was deposited onto freshly cleaved mica, dried under a clean stream of N2, rinsed with nanopure water, and dried again under N2. To study the change in aggregate size upon metal binding, the remaining 95 μL of 103 nM TAMRA-Aβ1–42 solution was incubated with 1 μL of 33 mM CuSO4, FeCl3, or ZnBr2 in H2O for 15 min, then deposited and dried onto a fresh mica surface in the same manner. To study the effect of chelation, 5 μL of 0.5 M EDTA in H2O or 20 μL of 0.018 M Ni-bme-dach in H2O was added to the resuspended TAMRA-Aβ1–42 and metal solution, incubated for 5 min, and then 5 μL of this solution was deposited onto and dried onto another freshly cleaved mica surface. Imaging was performed using a Digital Instruments Veeco AFM/LFM Instrument (Veeco Metrology group). Rotated monolithic, uncoated silicon AFM probes with a 125 μm tip length, a 300 kHz resonant frequency, and a 40 N/m spring constant (model Tap300G, Ted Pella) were used. The machine was operated in tapping mode, with the drive amplitude kept to a minimum, collecting scans of 2 μm × 2 μm at a slow scan frequency of 1.5–2.5 Hz and 512 × 512 scans per line. AFM images were analyzed using Digital Instruments software. TAMRA-Aβ1–42 peptide size was measured using cross-section analysis to create a size distribution histogram for each image.

Statistical Analysis

Fluorescence anisotropy was measured in triplicate for Aβ-only controls, metal-treated samples (Cu2+, Fe3+, Zn2+), and those treated with EDTA or Ni-bme-dach at pH 6.5 and 8.0 to assess pH-dependent effects. Baseline anisotropy (r ) was calculated from Aβ controls, and Δr values were derived as Δr = r conditionr for group comparisons. One-way ANOVA assessed differences among Aβ, metal, and metal + chelator groups, with Levene’s test confirming variance homogeneity (p > 0.69). Bonferroni-corrected pairwise t tests, followed by significant effects (p < 0.05), and effect sizes were reported as partial eta squared (η2). EDTA results were used to evaluate the reversal of Cu-, Fe-, and Zn-induced anisotropy shifts, whereas Ni-bme-dach tests assessed chelator selectivity. Both chelators exhibited robust Cu2+-specific reversal, partial Fe2+-reversal (pH-dependent), and negligible effects on Zn2+. Statistical analyses were performed in Python (NumPy, SciPy) with a significance level of p < 0.05. A statistical workflow is in the Supporting Information.

Results and Discussion

The following sections systematically build a metal-selectivity hierarchy by integrating fluorescence intensity, anisotropy, UV–vis spectroscopy, and nanoscale imaging. Each technique contributes a distinct dimension to understanding Cu-, Fe-, and Zn-specific aggregation and chelation.

Cu2+ is the Dominant Driver of Aβ Aggregation Across pH Conditions

Fluorescence intensity was first used to evaluate the effects of Cu2+, Fe3+, and Zn2+ on the TAMRA-Aβ1–42 behavior, thereby establishing a baseline for subsequent fluorescence anisotropy studies as a real-time probe of aggregation. All experiments employed 100% TAMRA-Aβ1–42, in which the metal-binding region is preserved to enable sensitive anisotropy detection, consistent with prior reports. , Intensity measurements confirmed that Cu2+ is the dominant driver of TAMRA-Aβ1–42 aggregation under both pH conditions, providing the foundation for anisotropy studies. For fluorescence intensity studies, TAMRA-Aβ1–42 was diluted to 55 nM in 10 mM HEPES buffer, excited at 545 nm, and emission spectra collected from 550 to 650 nm using a 570 nm long-pass filter to minimize scattering. Concentrations were maintained at 55 nM to prevent TAMRA self-quenching, and control experiments showed minimal fluorescence drift in TAMRA-Aβ1–42 alone, thereby confirming that the observed changes were metal- or chelator-induced rather than due to fluorophore interactions. Stock samples were stored in HFIP to maintain a stable, near-monomeric state. Metals were introduced by adding 2 μL of 33 mM CuSO4, FeCl3, or ZnBr2 for a final concentration of 65 μM and a peptide/metal ratio of ≈1:1200, followed by incubation for 10 min with gentle stirring before data collection. While elevated Cu2+ and Zn2+ concentrations (tens to hundreds of micromolar) in amyloid plaques and peri-plaque regions, , the metal/Aβ ratios employed here reflect conditions typical of plaque-associated environments.

In the representative spectra (Figure A), addition of Cu2+ produced a substantial quenching of TAMRA emission, 48% ± 12% at pH 8.0 (Figure A (a) and (b)) and 54% ± 24% at pH 6.5 (Figures B and S1). No similar quenching occurs when TAMRA-Aβ1–42 is incubated with an equivalent buffer for 5 min (Figure S2). This rapid change contrasts with the gradual fluorescence decay observed without metal ions, which decreased by 52 and 74% after 24 and 72 h, respectively (Figure S3). Fe3+ induced a similar magnitude of quenching (42% ± 29% at pH 8.0; 55% ± 12% at pH 6.5) (Figures B and S1), albeit with higher variability due to its heterogeneous coordination chemistry and redox activity. In contrast, Zn2+ produced only modest decreases (12% ± 12% at pH 8.0; 8.5% ± 4.1% at pH 6.5, Figures B and S1), consistent with weaker or more localized structural perturbation of the peptide.

1.

1

(A) Representative fluorescence spectra of (a) TAMRA-Aβ1–42, (b) after the addition of CuSO4, and (c) EDTA in 10 mM HEPES buffer pH 8.0. (B) Comparison of the % change (Δ) in fluorescence intensity (FLI) counts from monomeric TAMRA-Aβ1–42 and in the presence of CuSO4, FeCl3, and ZnBr2 and EDTA in 10 mM HEPES buffer pH 8.0 and pH 6.5. Final concentrations of the TAMRA-Aβ1–42, metals, and EDTA are 55 nM, 65 μM, and 2.5 mM respectively. Bars represent mean ± SD (n = 3). Statistical significance was assessed using one-way ANOVA with Tukey’s post hoc test.

To confirm that fluorescence changes were due to metal interactions with TAMRA-Aβ1–42, EDTA was used to remove Cu2+, Fe3+, or Zn2+ from the peptide. After adding EDTA (5 μL of 0.5 M, final concentration 2.5 mM; metal/chelator ratio 1:38), fluorescence intensity increased significantly (Figure A­(c)). Cu2+-Aβ1–42 complexes showed the strongest recovery, 3558% at pH 8.0 and 2065% at pH 6.5, far surpassing the premetal baseline (Figure A). Zn2+ exhibited a moderate return (727% at pH 8.0; 174% at pH 6.5), whereas Fe3+ produced limited recovery (288% at pH 8.0; 58% at pH 6.5), consistent with incomplete Fe3+ chelation under mildly acidic conditions (Figures B and S1). Notably, EDTA addition to TAMRA-Aβ1–42, even in the absence of metals, resulted in a substantial increase in fluorescence intensity or “hyper-recovery” (Figure S4). The significant increase in fluorescence intensity upon addition of EDTA is surprising and may reflect multiple mechanistic contributions. First, EDTA rapidly strips metals from their primary coordination sites on TAMRA-Aβ1–42, thereby reversing the metal-induced conformational transitions that promote TAMRA quenching. Second, EDTA disrupts transient interactions between the TAMRA fluorophore and the nearby Tyr10 residue, an established quenching pathway, thereby generating a pronounced “quenching-release” or fluorescence “hyper-recovery” effect. , Third, EDTA relaxes peptide–peptide contacts, restoring a more extended, monomer-like conformation that is intrinsically more emissive. Fourth, trace counterions may remain after peptide purification and are chelated by EDTA, as the product sheet reports 95% purity by HPLC. However, the vendor (Anaspec.com) reports that no trace metals are present in the purchased peptide stock.

Statistical analysis of percent change in fluorescence confirms strong metal- and pH-dependent effects. Cu2+ produced the most pronounced response at both pH values, with a highly significant overall effect at pH 8.0 (F(2,6) = 39.41, p = 0.0004, η2 = 0.93) and all pairwise comparisons remaining significant after correction (p adj ≤0.010), consistent with robust quenching and EDTA-driven hyper-recovery. At pH 6.5, Cu2+ again showed a significant group effect (F(2,6) = 11.21, p = 0.0094, η2 = 0.79), though pairwise comparisons did not survive correction, reflecting increased variability while preserving trend direction. Fe3+ displayed a significant effect at pH 8.0 (F(2,6) = 13.65, p = 0.0058, η2 = 0.82) without significant corrected pairwise differences; while at pH 6.5, a borderline ANOVA (F(2,6) = 4.22, p = 0.0717) and selective significance between Fe3+ and TAMRA-Aβ1–42 (p adj = 0.0036) indicate partial EDTA-mediated recovery. Zn2+ induced more modest effects, with a significant but weakly resolved response at pH 8.0 (F(2,6) = 5.95, p = 0.0377, η2 = 0.66) and a stronger, EDTA-responsive effect at pH 6.5 (F(2,6) = 21.33, p = 0.0019, η2 = 0.88; p adj ≈ 0.03).

The fluorescence quenching and recovery observed in the presence of Cu2+ are consistent with prior 1H and 15N NMR studies, which show that Cu2+ binding to the Aβ monomer backbone induces oligomerization and that this process is fully reversible upon EDTA treatment. , The differential recovery observed across metals further highlights distinct interaction modes. Zn2+’s modest quenching and recovery are consistent with 2D and 3D 15N NMR evidence showing weaker, more localized binding involving His6, His11, His13, Asp1, and residues near Asp23–Lys28. In contrast, Fe3+’s limited recovery reflects its more heterogeneous and pH-sensitive coordination environment, involving carboxylate residues including Glu3, Glu11, Glu22, Asp1, and Asp23. Together, these metal-dependent fluorescence signatures confirm that each ion interacts distinctly with TAMRA-Aβ1–42, with Cu2+ producing the most pronounced conformational and aggregation-related perturbations.

Fluorescence Anisotropy Enables Real-Time Monitoring of Metal-Induced Aggregation

Because fluorescence intensity studies showed rapid, metal-specific conformational changes in TAMRA-Aβ1–42; steady-state fluorescence anisotropy was used to measure changes in hydrodynamic radius from early oligomer formation, with EDTA as a benchmark for reversibility. These measurements focused on short-time aggregation equilibria, with samples incubated for approximately 10 min at room temperature, in contrast to the longer times required for fibril maturation at 37 °C. Briefly, 55 nM TAMRA-Aβ1–42 in 10 mM HEPES buffer was excited at λmax 545 nm, and anisotropy was monitored at λmax 600 nm. After establishing a baseline, 65 μM CuSO4, FeCl3, or ZnBr2 (peptide/metal ≈1:1200) was added, and samples were gently stirred and incubated for 10 min before data acquisition for T = 1 min. Cu2+ produced the most significant anisotropy increase, rising from 0.12 ± 0.01 to 0.20 ± 0.01 at pH 8.0 (Δr = 0.09 ± 0.01) (Figure A). At pH 6.5, Cu2+ also promoted aggregation, though to a lesser extent (Δr = 0.03 ± 0.02), reflecting the known pH dependence of Cu-mediated Aβ coordination (Figure C). Fe3+ generated moderate anisotropy increases (Δr avg = 0.03 ± 0.01 at pH 8.0; 0.03 ± 0.02 at pH 6.5) (Figure B,C), consistent with formation of smaller, less compact aggregates, whereas Zn2+ produced negligible changes (−0.01 ± 0.02 at pH 8.0; −0.01 ± 0.01 at pH 6.5), reflecting its weak aggregation propensity. The relative magnitude of Δr correlates with known coordination modes: Cu2+ binding to His6/His13/His14 yields large, rigid assemblies; Fe3+ interacts with Tyr10 and carboxylates to form smaller structures; and Zn2+ coordinates histidines and carboxylates without promoting aggregation. Importantly, buffer-only controls produced no anisotropy change (Figure A, orange trace), confirming that Δr reflects metal coordination rather than spontaneous self-association. Addition of EDTA returned anisotropy values close to the metal-free baseline; however, accompanying fluorescence data indicate that EDTA also perturbs the local fluorophore environment beyond metal removal. These results verify that anisotropy changes originate from metal-induced aggregation with EDTA as an internal control for reversibility.

2.

2

(A) A representative fluorescence anisotropy plot of (a) TAMRA-Aβ1–42 in 10 mM HEPES pH 8.0 with sequential additions of (b) 2 mL of CuSO4 and (c) 5 mL EDTA (blue) and TAMRA-Aβ1–42 with (a) first eq 2 mL and (b) second eq 5 mL of 10 mM HEPES pH 8.0 (orange). Note: that after each addition, there is a 10 min incubation period before data is collected. Comparison of the average anisotropies of TAMRA-Aβ1–42 in 10 mM HEPES, (B) pH 8.0, or (C) pH 6.5, before and after the addition of metal and EDTA. The final concentrations of TAMRA-Aβ1–42, metal ions, and EDTA are 55 nM, 65 μM, and 2.5 mM. Bars represent mean ± SD (n = 3). Statistical significance was evaluated using one-way ANOVA with Tukey post hoc corrections.

The observed anisotropy responses are physically consistent with the short excited-state lifetime of the TAMRA fluorophore (≈2–3 ns), which limits steady-state anisotropy sensitivity to species undergoing rapid rotational diffusion. Consequently, anisotropy primarily reports on early stage oligomers and local rigidity changes rather than large, slowly rotating aggregates whose rotational correlation times exceed the fluorescence lifetime. Within this framework, statistical analysis confirms a strong metal-dependent hierarchy in anisotropy response. Cu2+ produced highly significant differences among TAMRA-Aβ1–42, Cu2+, and Cu2+ + EDTA at both pH values (pH 6.5: F(2,6) = 24.56, p = 0.0013, η2 = 0.89; pH 8.0: F(2,6) = 315.34, p ≈ 10–6, η2 = 0.99), with post hoc comparisons confirming complete reversal of Cu-induced anisotropy upon EDTA addition (p ≤ 0.024). Fe3+ exhibited more minor but significant group effects (pH 6.5: F(2,6) = 16.86, p = 0.0034; pH 8.0: F(2,6) = 7.89, p = 0.0209), consistent with partial anisotropy reversal at pH 6.5 and minimal response at pH 8.0. In contrast, Zn2+ produced anisotropy values near baseline at both pH conditions, with no statistically significant group differences observed. While abrupt anisotropy increases can, in some systems, signal liquid–liquid phase separation, the absence of micron-scale droplets and the low peptide concentrations used here indicate that the observed responses arise from nanoscale aggregation. Together, these results establish a clear hierarchy in early stage aggregation sensitivity (Cu2+ > Fe3+ > Zn2+) and demonstrate that EDTA restores anisotropy to baseline across all metal conditions (Figure A–C). ,

Ni-bme-dach Selectively Reverses Cu-Induced Aggregation Without Broad Metal Stripping

Ni-bme-dach, was next evaluated as a targeted chelator to determine whether it could selectively reverse Cu-induced Aβ1–42 aggregation without the broad, nondiscriminating metal removal characteristic of EDTA. To assess this selectivity, 20 μL of 0.02 M Ni-bme-dach was added to TAMRA-Aβ1–42 samples containing 110 nM peptide and 0.33 mM metal ions (metal: peptide = 1:300, metal: chelator = 1:11). Although the metal/peptide ratios differ between EDTA and Ni-bme-dach conditions, both sets were intentionally designed to maintain excess metal and chelator to ensure complete competitive binding under their respective regimes. Fluorescence anisotropy was measured before and after the addition of Ni-bme-dach at pH 8.0 and 6.5 to monitor metal coordination and chelation. For Cu2+, anisotropy measurements showed that metal binding induced moderate aggregation (Δr avg = 0.02 ± 0.01 at pH 8.0; 0.03 ± 0.01 at pH 6.5) (Figure A,B). Strikingly, the addition of Ni-bme-dach completely reversed the increases in anisotropy at both pH values, restoring monomer-like rotational mobility and demonstrating complete disassembly of Cu–Aβ aggregates. This complete reversal confirms that Ni-bme-dach effectively disrupts Cu–Aβ interactions. The extent of anisotropy recovery parallels the Cu-specific reversibility observed with EDTA, yet, as described below, the underlying mechanism differs significantly. In addition, a slightly smaller recovery at pH 6.5 is consistent with decreased stability of the Cu-histidine coordination under mildly acidic conditions. Statistical analysis of the Δr values confirmed the Cu-specific nature of Ni-bme-dach reversal. At both pH 6.5 and 8.0, one-way ANOVA revealed significant differences among TAMRA-Aβ1–42, Cu2+-treated, and Cu2+ + Ni-bme-dach samples (pH 6.5: F(2,6) = 18.40, p = 0.0028; pH 8.0: F(2,6) = 11.95, p = 0.0081). Post hoc comparisons demonstrated that Cu2+ produced a significantly larger Δr than both TAMRA-Aβ1–42 (p = 0.018 at pH 6.5) and Cu2+ + Ni-bme-dach (p = 0.013 at pH 6.5; p = 0.039 at pH 8.0), whereas the Ni-bme-dach-treated samples were statistically indistinguishable from baseline at both pH values (p ≥ 0.85). These results corroborate the complete functional reversal of Cu-induced aggregation by Ni-bme-dach and reinforce that the chelator restores peptide mobility to monomer-like levels.

3.

3

Comparison of the average anisotropies of TAMRA-Aβ1–42 in (A) 10 mM HEPES pH 8.0 or (B) 10 mM HEPES pH 6.5, and after the subsequent addition of metal ions and Ni-bme-dach. The final concentrations of TAMRA-Aβ1–42, metal ions, and Ni-bme-dach were 110 nM, 33 μM, and 0.35 mM, respectively. Bars represent mean ± SD (n = 3). Statistical significance was evaluated using one-way ANOVA with Tukey post hoc corrections.

In contrast to the robust Cu-specific reversibility, Ni-bme-dach produced substantially weaker effects on Fe- and Zn-induced aggregation across both pH values. At pH 8.0, Fe3+ caused only minimal aggregation (Δr avg = −0.01 ± 0.01) (Figure B), consistent with the extremely low solubility of Fe3+ under alkaline conditions where Fe­(OH)3 precipitates (K sp = 1.0 × 10–38). Correspondingly, the addition of Ni-bme-dach produced no measurable change in anisotropy (Δr avg ≈ 0.00 ± 0.01). Although one-way ANOVA indicated a significant overall effect among TAMRA-Aβ1–42, Fe3+, and Fe3+ + Ni-bme-dach (F(2,6) = 7.89, p = 0.0209, η2 = 0.72), post hoc comparisons showed only a borderline difference between Fe3+ and TAMRA-Aβ1–42 (p = 0.050) and no significant difference between Fe3+ and Fe3+ + Ni-bme-dach (p = 1.0). Thus, at pH 8.0, the minimal magnitude of Δr changes reflects limited soluble Fe3+ available to interact with TAMRA-Aβ1–42, and Ni-bme-dach does not significantly perturb these already minimal effects. At pH 6.5, where Fe3+ remains soluble, metal binding produced anisotropy increases comparable to those observed for Cu2+r avg = 0.03 ± 0.01). Ni-bme-dach partially reversed this increase, reducing Δr by approximately 58% to Δr avg≈ 0.013 ± 0.01. One-way ANOVA confirmed a significant overall effect among conditions (F(2,6) = 16.86, p = 0.0034, η2 = 0.85). Consistent with the observed Δr values, Fe3+ significantly differed from TAMRA-Aβ1–42 (p = 0.015), while the Fe3+ vs Fe3+ + Ni-bme-dach comparison did not remain significant after correction (p = 0.064). Fe3+ + Ni-bme-dach was also indistinguishable from TAMRA-Aβ1–42 (p = 0.24), consistent with partial, but not complete, reversal of Fe-induced aggregation.

Zn2+ induced minimal aggregation at both pH 8.0 and 6.5 (Δr avg = −0.01 ± 0.01; Figure A,B), and addition of Ni-bme-dach produced no measurable change in anisotropy (Δr avg ≈ −0.01 to 0.00 ± 0.01), indicating negligible Zn2+ extraction under these conditions. Consistent with these weak responses, anisotropy is inherently less sensitive to the modest structural perturbations associated with Zn–Aβ interactions. In contrast, Fe3+ exhibited partial, pH-dependent reversibility, whereas only Cu2+ showed a statistically validated, near-complete restoration of monomer-like anisotropy upon Ni-bme-dach treatment. Lastly, Ni-bme-dach exhibited fluorescence intensity comparable to that of the metal-free peptide, without exceeding it, indicating that it effectively extracts Cu2+ via direct metal extraction and complexation. This selective behavior suggests it does not disrupt local TAMRA–Tyr10 interactions or cause significant conformational changes. Additionally, the lack of anisotropy changes with Zn2+ indicates that this optical platform is not ideal for assessing Zn2+ chelators, as any structural changes are subtle. Furthermore, the solubility of metal species, as in the case of Fe3+ at pH 8.0, is crucial for binding to and aggregating TAMRA-Aβ1–42.

Molecular Evidence for Targeted Cu2+ Chelation by Ni-bme-dach

UV–vis spectroscopy was used to probe metal coordination and chelation underlying the anisotropy responses directly. The spectrum of TAMRA-Aβ1–42 displays a weak absorption at λmax = 552 nm, characteristic of the TAMRA fluorophore. CuSO4 exhibits a shoulder at λmax = 246 nm, which red-shifts to 250 nm upon addition to TAMRA-Aβ1–42, indicating Cu-peptide coordination (Figure A). Ni-bme-dach shows a prominent d–d transition at λmax ≈ 456 nm, arising from N, S-chelation of Ni2+. Upon addition of Ni-bme-dach to Cu2+-TAMRA-Aβ1–42, a new shoulder emerges at λmax ≈ 341 nm alongside the Ni-centered d–d band, consistent with Cu extraction from the peptide and formation of a Cu–Ni-bme-dach complex (Figure A, inset). At pH 6.5, similar weak features are observed at λmax ≈ 339 and 450 nm. These spectral signatures closely match those of the reported [(Ni-bme-dach)3Cu2Br]­Br complex, which exhibits weak d–d transitions near 390 and 440 nm (Figure S6A), supporting formation of a Cu–NiN2S2 “paddlewheel”-type structure.

4.

4

UV–vis spectroscopy comparing changes in the absorbance of TAMRA-Aβ1–42, (A) CuII, (B) ZnII, or (C,D) FeIII and Ni-bme-dach in 10 mM phosphate buffer pH 8.0. as well as (D) FeIII and Ni-bme-dach in 10 mM HEPES buffer pH 6.5. Final concentrations of the TAMRA-Aβ1–42, metals, and Ni-bme-dach were 110 nM, 33 μM, and 0.35 mM, respectively.

In contrast, Zn2+, a d10 metal, does not produce distinct metal–ligand charge-transfer features upon binding to TAMRA-Aβ1–42 (Figure B). Addition of Ni-bme-dach to Zn2+–TAMRA-Aβ1–42 at either pH 8.0 or 6.5 leads to increased absorbance of Ni-bme-dach-associated MLCT bands at λmax = 227 and 274 nm, while the Ni-centered d–d transition at λmax ≈ 452 nm remains unchanged. These spectra closely resemble those of Ni-bme-dach3(ZnCl)2, which exhibits absorptions at λmax = 226, 270, and 460 nm, consistent with weak Zn2+ coordination by Ni-bme-dach (Figure S6B). The minimal UV–vis perturbations observed are consistent with the weak, nonaggregating nature of Zn–Aβ interactions.

UV–vis studies involving Fe3+ are more complex due to its redox activity and pH-dependent solubility. At pH 8.0, FeCl3 displays an absorption at λmax = 278 nm that undergoes a ∼15 nm blue shift to ∼263 nm upon addition to TAMRA-Aβ1–42, indicating metal coordination (Figure C). This feature diminishes upon the addition of Ni-bme-dach, consistent with reversible Fe binding. At pH 6.5, Ni-bme-dach induces only weak spectral features near λmax ≈ 338 and 450 nm (Figure D), indicating modest Fe-ligand interactions. Although the structure of the resulting Fe–Ni-bme-dach after peptide chelation is unclear, literature precedents indicate that Fe can coordinate to the Ni-bme-dach in monodentate or bidentate fashion. Together, these pH-dependent spectral changes suggest that Fe redox behavior and solubility limit both its interaction with Aβ1–42 and its chelation by Ni-bme-dach.

Collectively, the UV–vis data provide molecular-level support for the selective extraction of Cu2+ from Aβ1–42 by Ni-bme-dach, resulting in the formation of a well-defined [(Ni-bme-dach)3Cu2Br]­Br. In contrast, Zn2+ and Fe3+ exhibit weaker and more reversible interactions, consistent with their minimal or partial responses in anisotropy measurements. For comparison, UV–vis spectra obtained in the presence of EDTA show complete removal of both Cu2+ and Fe3+ at pH 8.0 and 6.5, yielding characteristic Cu-EDTA and Fe-EDTA signatures (Figure S7) and highlighting the nonselective nature of EDTA relative to Ni-bme-dach.

Morphological and Nanoscale Validation via TEM and AFM

Because fluorescence anisotropy demonstrated that Ni-bme-dach selectively reverses Cu-induced Aβ aggregation, and UV–vis identified the coordination states and metal-extraction mechanisms, nanoscale imaging was used to determine how these molecular events alter aggregate morphology. Fluorescence microscopy was not used because early stage assemblies at nanomolar peptide concentrations are too small for diffraction-limited imaging. AFM and TEM offer better nanoscale characterization to support Ni-bme-dach’s role as a selective Cu-extracting ligand alongside solution-phase anisotropy measurements. All samples were prepared under conditions identical to those used for anisotropy measurements, thereby enabling a direct correlation between hydrodynamic radius and nanoscale morphology. Briefly, baseline TEM images of TAMRA-Aβ1–42 stained with uranyl acetate revealed an extensive network of small aggregates, likely oligomers (Figure (i)). These structures are nanoscale oligomers and aggregate networks, not mature fibrillar plaques. Due to low peptide concentrations and short incubation times, micrometer-scale plaques are not expected, and terminology has been updated for clarity. Upon Cu2+ addition, a vast network of nanoscale aggregates formed, appearing interconnected and significantly denser, often adopting globular and clustered structures (Figures (ii) and S8). The shift in the size of the extensive network of nanoscale aggregates is consistent with the increase in anisotropy observed in solution (Figure ). Interestingly, TEM images after Ni-bme-dach treatment still showed significant peptide aggregation, which appeared less dense but more compact than TAMRA-Aβ1–42 alone (Figures (iii) and S8). The network morphology made it challenging to measure the dimensions of the nanoscale aggregates, likely due to drying effects and the presence of metal-chelate complexes that were not removed from the samples before deposition.

5.

5

TEM images of (i) 1.10 μM TAMRA-Aβ1–42 in 10 mM phosphate buffer pH 8.0, with additions of (ii) CuII, (iii) CuII and Ni-bme-dach, (iv) ZnII, (v) ZnII and Ni-bme-dach, (vi) FeIII, and (vii) FeIII and Ni-bme-dach. Final concentrations of metals and Ni-bme-dach were 0.33 mM and 0.35 mM, respectively. The scale bar for all images is 100 nm.

TEM images after Zn2+ addition show moderate compaction of TAMRA-Aβ1–42 nanoscale aggregates, resulting in a thinner clustered network that appears less dense in the presence of Ni-bme-dach, indicating that the ligand does have mild disruption of Zn-Aβ interactions or peptide-to-peptide interactions (Figure (iv) and (v)). This is consistent with the relatively minor anisotropy changes, confirming that Zn2+ induces mild peptide–peptide interactions. In contrast, TEM images of Cu2+ and Zn2+-TAMRA-Aβ1–42 nanoscale aggregates after the treatment with broad-spectrum chelator EDTA showed a significant reduction in aggregate size and network interactions (Figure S9). Lastly, Fe3+ also induced an extensive and dense large network of nanoscale aggregates similar to Cu2+ (Figure (iv)). However, in the presence of Ni-bme-dach, aggregate size and density are drastically reduced, yielding smaller spherical structures with little evidence of network-like features (Figure vii), indicating that Ni-bme-dach strongly disrupts Fe3+-induced aggregation.

Fluorescence anisotropy indicates that Ni-bme-dach reverses metal-induced TAMRA-Aβ1–42 aggregation, whereas TEM reveals residual nanoscale aggregates due to differences in the techniques’ respective sensitivity. Anisotropy is sensitive to the rotational dynamics of TAMRA-Aβ1–42 in solution, where larger, metal-cross-linked structures decrease molecular mobility and thus lower anisotropy, even if smaller aggregates remain. In contrast, TEM captures all electron-dense species after drying, including baseline self-assembly and aggregated forms not reflected in the anisotropy signal. Consequently, Ni-bme-dach reduces metal-driven aggregation, as seen in anisotropy, but does not completely prevent Aβ-Aβ association in the absence of solvent, which accounts for the observed nanoscale aggregates in TEM. Across all chelator-lacking conditions, a clear hierarchy emerges in how metals shape Aβ aggregation. Cu2+ and Fe3+ induce the most pronounced structural perturbations, generating dense, compact, and irregular nanoscale aggregates, whereas Zn2+ produces only modest morphological changes. These baseline behaviors define the relative ability of each metal to perturb TAMRA-Aβ1–42 structure and serve as a critical reference for interpreting ligand-mediated effects across the data set.

AFM measurements reinforced the TEM observations, quantified the hierarchy of chelation responsiveness, and provided information about the relative sizes of the species formed. TAMRA-Aβ1–42 alone exhibits small spherical structures (2.1 ± 0.6 nm height; 7.5 ± 1.3 nm width) (Figures (i) and S10). In the presence of Cu2+ the nanoscale aggregates are large (9.6 ± 1.6 nm height; 154 ± 74.9 nm width) (Figure (ii)) and is significantly decreased to 4.4 ± 1.2 nm and 51.9 ± 21.6 nm in the presence of Ni-bme-dach (Figures (iii) and (S10)), representing a near-complete collapse that closely mirrors the full anisotropy recovery and UV–vis evidence for Cu2+extraction. Zn2+ caused only modest increases in aggregate size (7.3 ± 2.0 nm height), and Ni-bme-dach had no detectable structural impact on these assemblies (Figures (iv) and (v) and S12), consistent with Zn2+ evidence within for its low propensity to induce significant TAMRA-Aβ1–42. Fe3+ aggregates displayed heterogeneous dimensions (8.4 ± 6.6 nm height; 90 ± 80 nm width) and remained large following Ni-bme-dach treatment (10.5 ± 10.1 nm height; 166 ± 138 nm width) (Figures (vi–vii) and S13), consistent with 58% recovery observed in the anisotropy studies and the aggregates observed by TEM. Overall, AFM confirms the selectivity hierarchy: Cu (fully reversible) > Fe (partially reversible) ≫ Zn (no effect), a pattern that aligns precisely with Ni-bme-dach thermodynamic preferences and mechanistic mode of action.

6.

6

AFM image scans with 2 × 2 μm xy and 5 nm total z-range of (i) 0.55 μM Aβ1–42 in 10 mM phosphate buffer pH 8.0, with additions of (ii) CuII, (iii) CuII and Ni-bme-dach, (iv) ZnII, (v) ZnII and Ni-bme-dach, (vi) FeIII, and (vii) FeIII and Ni-bme-dach. Final concentrations of metals and Ni-bme-dach were 0.33 mM and 3.6 mM, respectively.

7.

7

UV–vis spectroscopy comparing changes in the absorbance of TAMRA-Aβ1–42, Fe2+, and Ni-bme-dach in (A) 10 mM phosphate buffer pH 8.0 and (B) 10 mM HEPES pH 6.5, individually and in combination with each other. Final concentrations of the TAMRA-Aβ1–42, metals, and Ni-bme-dach were 55 nM, 66 μM, and 2.5 mM, respectively.

Upon introduction of Ni-bme-dach, the ligand remodels these metal-associated aggregates in a distinctly metal-dependent manner. Cu-derived aggregates undergo the most substantial structural disassembly, consistent with selective chelation observed by fluorescence anisotropy and UV–vis spectroscopy. Fe-derived aggregates exhibit only partial reorganization, and Zn-associated structures remain essentially unchanged, reflecting their weaker interactions with both Aβ and Ni-bme-dach. Collectively, these ligand-treated morphologies demonstrate that Ni-bme-dach does not function as a broad-spectrum chelator and instead acts through selective disruption of Cu-driven assemblies, while minimally influencing metals that perturb Aβ less strongly. Note that the residual aggregates visible by TEM and AFM reflect drying-induced stabilization of weakly associated Aβ species, and do not contradict the complete restoration of monomer-like rotational mobility observed in solution by anisotropy.

Integrated Mechanistic Model of Metal-Specific Aggregation and Chelation

Across fluorescence anisotropy, UV–vis spectroscopy, TEM, and AFM, a unified mechanistic framework emerges in which Cu2+, Zn2+, and Fe3+ drive fundamentally distinct Aβ1–42 aggregation pathways with sharply different susceptibilities to chelation. Among these metals, Cu2+ uniquely promotes large, dense, and highly dynamic aggregates, as evidenced by the largest anisotropy increases (Figure A–C), characteristic Cu-Aβ charge-transfer features in UV–vis spectra (Figure A), and extensive network-like assemblies observed by TEM and AFM (Figures (ii) and (ii)). These Cu-derived aggregates are fully reversible, collapsing to monomer-like states upon treatment with either EDTA or Ni-bme-dach, as reflected by complete anisotropy recovery (Figures A and A-B) and pronounced reductions in aggregate dimensions by AFM (Figures (iii) and S11). This identifies Cu2+ as the only metal whose aggregation pathway is fully amenable to chelation-driven disassembly.

Central to this reversibility is Ni-bme-dach’s selective Cu-extraction mechanism. UV–vis spectroscopy reveals direct capture of Cu2+ into a discrete Cu–Ni complex, manifested as new absorption features near ∼341 and 456 nm (Figures A; S6A). This specific coordination pathway restores anisotropy and reduces aggregate size without inducing fluorescence hyper-recovery, demonstrating that Ni-bme-dach removes Cu2+ without broadly stripping metals or perturbing local fluorophore–peptide interactions. In contrast, EDTA reverses aggregation by indiscriminately removing metals, producing fluorescence hyper-recovery, global anisotropy collapse, and extensive aggregate dissolution across all metals.

Zn2+ forms small, amorphous, weakly associated oligomers that exhibit minimal fluorescence quenching, negligible anisotropy changes, and modest particle growth. Because Zn2+ binds weakly to Aβ1–42 and Ni-bme-dach exhibits low Zn2+ affinity, Zn-induced assemblies remain largely unaffected by chelation. Fe3+ induces a third, more complex aggregation regime governed by redox chemistry and pH-dependent solubility. Fe-derived aggregates are heterogeneous and intermediate in size (Figures (vi) and (vi)), show complete reversibility with EDTA, and only partial reversibility with Ni-bme-dach (Figures and ). UV–vis spectra reveal extensive Fe3+/Fe2+ interconversion: FeCl3 undergoes a blue shift from 278 to ∼263 nm upon binding to TAMRA-Aβ1–42 at pH 8.0 (Figure C,D), closely resembling FeCl2 binding behavior under alkaline conditions (Figure A), while FeCl2 features disappear upon peptide addition at pH 6.5 (Figures B and S16). These transitions indicate that Fe coordination is dictated by redox speciation and solubility, with Fe2+ oxidizing before binding at pH 8.0, Fe3+ reducing before binding at pH 6.5, and both species converting to insoluble Fe­(OH)3 under more acidic conditions (Figure S16). This mechanism is consistent with reports that Aβ can reduce Fe3+ to redox-active Fe2+, providing a plausible biochemical pathway for Fe-mediated redox cycling and ROS generation in Alzheimer’s disease lesions. Together, these observations define a mechanistic hierarchy in which Cu2+ uniquely forms a fully reversible aggregation pathway, whereas Zn2+ and Fe3+ drive aggregation processes with restricted chelation sensitivity.

Conclusion

Taken together, this work establishes a clear metal-specific hierarchy in Aβ1–42 aggregation and its susceptibility to chelation. Cu2+ emerges as the most potent promoter of conformational reorganization, producing large, dynamic aggregates that, importantly, remain fully reversible upon chelation. Fe3+ and Zn2+ generate smaller or structurally heterogeneous aggregates shaped by redox cycling and weaker coordination, and these assemblies exhibit limited or negligible responsiveness to selective chelation. Within this landscape, EDTA and Ni-bme-dach display mechanistically distinct behaviors. EDTA disrupts all metal-Aβ states through nonselective stripping, yielding a hyperfluorescent, near-monomeric end point that masks key features of metal-specific aggregation. In contrast, Ni-bme-dach extracts Cu2+ through formation of spectroscopically distinct Cu–Ni complexes, fully reversing Cu-induced aggregation while minimally perturbing Fe- or Zn-associated species. This selectivity is reflected across fluorescence anisotropy, UV–vis coordination signatures, and nanoscale morphology, demonstrating that Ni-bme-dach does not act as a general metal remover but as a targeted Cu-extracting ligand while leaving Fe and Zn coordination largely intact. Consequently, this work identifies a viable design principle for next-generation, metal-selective AD chelation strategies.

A key strength of this study is the integration of real-time anisotropy kinetics with UV–visible spectroscopy and TEM/AFM imaging to build a unified mechanistic model of metal-driven aggregation and chelation-mediated disassembly. To our knowledge, this is one of the few direct comparative analyses of selective and nonselective chelation in metallopeptide aggregation. While the focus here is on early stage aggregation under controlled conditions, the mechanistic principles revealed, particularly the importance of thermodynamic selectivity and ligand field matching, provide a foundation for rational design of next-generation Cu-targeted chelators. These methods enable future work to compare TAMRA-Aβ1–42 kinetics with unlabeled Aβ monitored by ThT or orthogonal probes, thereby further validating the correspondence between labeled and native aggregation pathways. More broadly, these results illustrate how coordination chemistry can be leveraged to selectively modulate metallopeptide structure while preserving essential metal–protein equilibria, a necessary criterion for therapeutic intervention.

Supplementary Material

ao5c11345_si_001.pdf (1.9MB, pdf)

Acknowledgments

We sincerely thank Pokhraj Ghosh for his outstanding contributions to the synthesis of the Ni-bme-dach compound. His meticulous experimental work and dedication to the project significantly advanced our understanding of this complex molecule and its interactions with Aβ. We also gratefully acknowledge Marcetta Y. Darensbourg (Texas A&M University) for the generous gift of this compound. The authors further thank Julie and William Reiersgaard for their generous support of this research and their commitment to advancing student-centered scientific training. Their contributions were critical in enabling meaningful student involvement in both the experimental and analytical components of this work and in fostering the educational environment that made this study possible.

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsomega.5c11345.

  • The Supporting Information contains supplemental fluorescence spectra, UV–vis spectroscopy, TEM images, AFM image scans, AFM histogram analyses, and statistical analysis workflows supporting the conclusions of this study. Specifically, it includes representative fluorescence spectra of TAMRA-Aβ1–42 under metal binding and chelation conditions at pH 6.5 and 8.0 (Figures S1–S5), UV–vis spectroscopy examining metal-peptide and chelator interactions (Figures S6, S7, S15, and S16), TEM images illustrating metal-induced aggregation and chelator-mediated reversal (Figures S8 and S9), AFM image scans and corresponding height distribution histograms quantifying aggregate morphology and reversibility (Figures S10–S14), and a detailed description of the statistical workflow used for fluorescence intensity and anisotropy analyses (PDF)

§.

A.N.S. and E.K.A contributed equally to this work. Fluorescence Studies were completed by A.S., E.A., D.F., E.L., J.G. TEM studies were completed by A.S., while E.A. completed the AFM studies. The conception of the study, experimental design, data analysis, and writing were completed by M.M, A.S., E.A, and DC.

The authors declare no competing financial interest.

References

  1. Bourassa M. W., Leskovjan A. C., Tappero R. V., Farquhar E. R., Colton C. A., Van Nostrand W. E., Miller L. M.. Elevated copper in the amyloid plaques and iron in the cortex are observed in mouse models of Alzheimer’s disease that exhibit neurodegeneration. Biomed. Spectrosc. Imaging. 2013;2(2):129–139. doi: 10.3233/BSI-130041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Wang P., Wang Z.-Y.. Metal ions influx is a double edged sword for the pathogenesis of Alzheimer’s disease. Ageing Res. Rev. 2017;35:265–290. doi: 10.1016/j.arr.2016.10.003. [DOI] [PubMed] [Google Scholar]
  3. Lovell M. A., Robertson J. D., Teesdale W. J., Campbell J. L., Markesbery W. R.. Copper, iron and zinc in Alzheimer’s disease senile plaques. J. Neurol. Sci. 1998;158(1):47–52. doi: 10.1016/S0022-510X(98)00092-6. [DOI] [PubMed] [Google Scholar]
  4. Wang P., Wang Z. Y.. Metal ions influx is a double edged sword for the pathogenesis of Alzheimer’s disease. Ageing Res. Rev. 2017;35:265–290. doi: 10.1016/j.arr.2016.10.003. [DOI] [PubMed] [Google Scholar]
  5. Dong J., Atwood C. S., Anderson V. E., Siedlak S. L., Smith M. A., Perry G., Carey P. R.. Metal Binding and Oxidation of Amyloid-β within Isolated Senile Plaque Cores: Raman Microscopic Evidence. Biochemistry. 2003;42(10):2768–2773. doi: 10.1021/bi0272151. [DOI] [PubMed] [Google Scholar]
  6. Kim A. C., Lim S., Kim Y. K.. Metal Ion Effects on Aβ and Tau Aggregation. Int. J. Mol. Sci. 2018;19(1):128. doi: 10.3390/ijms19010128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Tarnacka B., Jopowicz A., Maślińska M.. Copper, Iron, and Manganese Toxicity in Neuropsychiatric Conditions. Int. J. Mol. Sci. 2021;22(15):7820. doi: 10.3390/ijms22157820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jomova K., Alomar S. Y., Valko R., Nepovimova E., Kuca K., Valko M.. The role of redox-active iron, copper, manganese, and redox-inactive zinc in toxicity, oxidative stress, and human diseases. EXCLI J. 2025;24:880–954. doi: 10.17179/excli2025-8449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Zheng N., Zhou Q., Chen Z., Xie L., Yang X., Chen Z., Wang F., Sun Q., Du J., Lin J., Li L., Li B.. Cuproptosis: mechanisms and links with Alzheimer’s disease. J. Neurophysiol. 2025;134(6):1853–1876. doi: 10.1152/jn.00370.2025. [DOI] [PubMed] [Google Scholar]
  10. Castellani R. J., Honda K., Zhu X., Cash A. D., Nunomura A., Perry G., Smith M. A.. Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease. Ageing Res. Rev. 2004;3(3):319–326. doi: 10.1016/j.arr.2004.01.002. [DOI] [PubMed] [Google Scholar]
  11. Cherny R. A., Barnham K. J., Lynch T., Volitakis I., Li Q.-X., McLean C. A., Multhaup G., Beyreuther K., Tanzi R. E., Masters C. L., Bush A. I.. Chelation and Intercalation: Complementary Properties in a Compound for the Treatment of Alzheimer’s Disease. J. Struct. Biol. 2000;130(2–3):209–216. doi: 10.1006/jsbi.2000.4285. [DOI] [PubMed] [Google Scholar]
  12. McLachlan D. R. C., Kruck T. P. A., Kalow W., Andrews D. F., Dalton A. J., Bell M. Y., Smith W. L.. Intramuscular desferrioxamine in patients with Alzheimer’s disease. Lancet. 1991;337(8753):1304–1308. doi: 10.1016/0140-6736(91)92978-B. [DOI] [PubMed] [Google Scholar]
  13. Padmanabhan, G. ; Becue, I. ; Smith, J. B. . Clioquinol. In Analytical Profiles of Drug Substances, Klaus Florey, A. A. A.-B. G. A. F. H. G. B. ; Lee, T. G. , Eds.; Academic Press, 1990; Vol. 18, pp 57–90. [Google Scholar]
  14. Ritchie C. W., Bush A. I., Mackinnon A., Macfarlane S., Mastwyk M., MacGregor L., Kiers L., Cherny R., Li Q. X., Tammer A., Carrington D., Mavros C., Volitakis I., Xilinas M., Ames D., Davis S., Beyreuther K., Tanzi R. E., Masters C. L.. Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial. Arch. Neurol. 2003;60(12):1685–1691. doi: 10.1001/archneur.60.12.1685. [DOI] [PubMed] [Google Scholar]
  15. Lannfelt L., Blennow K., Zetterberg H., Batsman S., Ames D., Harrison J., Masters C. L., Targum S., Bush A. I., Murdoch R., Wilson J., Ritchie C. W.. Safety, efficacy, and biomarker findings of PBT2 in targeting Abeta as a modifying therapy for Alzheimer’s disease: a phase IIa, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2008;7(9):779–786. doi: 10.1016/S1474-4422(08)70167-4. [DOI] [PubMed] [Google Scholar]
  16. Geng J., Li M., Wu L., Ren J., Qu X.. Liberation of Copper from Amyloid Plaques: Making a Risk Factor Useful for Alzheimer’s Disease Treatment. J. Med. Chem. 2012;55(21):9146–9155. doi: 10.1021/jm3003813. [DOI] [PubMed] [Google Scholar]
  17. Scott L. E., Orvig C.. Medicinal Inorganic Chemistry Approaches to Passivation and Removal of Aberrant Metal Ions in Disease. Chem. Rev. 2009;109(10):4885–4910. doi: 10.1021/cr9000176. [DOI] [PubMed] [Google Scholar]
  18. Rodríguez-Rodríguez C., Telpoukhovskaia M., Orvig C.. The art of building multifunctional metal-binding agents from basic molecular scaffolds for the potential application in neurodegenerative diseases. Coord. Chem. Rev. 2012;256(19–20):2308–2332. doi: 10.1016/j.ccr.2012.03.008. [DOI] [Google Scholar]
  19. Cherny R. A., Atwood C. S., Xilinas M. E., Gray D. N., Jones W. D., McLean C. A., Barnham K. J., Volitakis I., Fraser F. W., Kim Y., Huang X., Goldstein L. E., Moir R. D., Lim J. T., Beyreuther K., Zheng H., Tanzi R. E., Masters C. L., Bush A. I.. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer’s disease transgenic mice. Neuron. 2001;30(3):665–676. doi: 10.1016/S0896-6273(01)00317-8. [DOI] [PubMed] [Google Scholar]
  20. Crouch P. J., Barnham K. J.. Therapeutic Redistribution of Metal Ions To Treat Alzheimer’s Disease. Acc. Chem. Res. 2012;45(9):1604–1611. doi: 10.1021/ar300074t. [DOI] [PubMed] [Google Scholar]
  21. Nuñez M. T., Chana-Cuevas P.. New Perspectives in Iron Chelation Therapy for the Treatment of Neurodegenerative Diseases. Pharmaceuticals. 2018;11(4):109. doi: 10.3390/ph11040109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Nyborg J. K., Peersen O. B.. That zincing feeling: the effects of EDTA on the behaviour of zinc-binding transcriptional regulators. Biochem. J. 2004;381(3):e3. doi: 10.1042/bj20041096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Xue C., Lin T. Y., Chang D., Guo Z.. Thioflavin T as an amyloid dye: fibril quantification, optimal concentration and effect on aggregation. R. Soc. Open Sci. 2017;4(1):160696. doi: 10.1098/rsos.160696. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Gregoire S., Irwin J., Kwon I.. Techniques for Monitoring Protein Misfolding and Aggregation in Vitro and in Living Cells. Korean J. Chem. Eng. 2012;29(6):693–702. doi: 10.1007/s11814-012-0060-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Girych M., Gorbenko G., Maliyov I., Trusova V., Mizuguchi C., Saito H., Kinnunen P.. Combined thioflavin T-Congo red fluorescence assay for amyloid fibril detection. Methods Appl. Fluoresc. 2016;4(3):034010. doi: 10.1088/2050-6120/4/3/034010. [DOI] [PubMed] [Google Scholar]
  26. Gijsbers A., Nishigaki T., Sánchez-Puig N.. Fluorescence Anisotropy as a Tool to Study Protein-protein Interactions. J. Vis. Exp. 2016;116:54640. doi: 10.3791/54640. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Zhao Y., Brener O., Andrzejewska E., Wei J., Reiß C., Tietz O., Knowles T. P. J., Aigbirhio F. I.. Detecting and Tracking β-Amyloid Oligomeric Forms and Dynamics In Vitro by a High-Sensitivity Fluorescent-Based Assay. ACS Chem. Neurosci. 2024;15(24):4383–4389. doi: 10.1021/acschemneuro.4c00312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Allsop D., Swanson L., Moore S., Davies Y., York A., El-Agnaf O. M. A., Soutar I.. Fluorescence Anisotropy: A Method for Early Detection of Alzheimer β-Peptide (Aβ) Aggregation. Biochem. Biophys. Res. Commun. 2001;285(1):58–63. doi: 10.1006/bbrc.2001.5123. [DOI] [PubMed] [Google Scholar]
  29. Mancini O., Wellbrock T., Rolinski O. J., Kubiak-Ossowska K., Mulheran P. A.. Probing beta amyloid aggregation using fluorescence anisotropy: experiments and simulation. Phys. Chem. Chem. Phys. 2018;20(6):4216–4225. doi: 10.1039/C7CP08217G. [DOI] [PubMed] [Google Scholar]
  30. Sulatskaya A. I., Rychkov G. N., Sulatsky M. I., Mikhailova E. V., Melnikova N. M., Andozhskaya V. S., Kuznetsova I. M., Turoverov K. K.. New Evidence on a Distinction between Aβ40 and Aβ42 Amyloids: Thioflavin T Binding Modes, Clustering Tendency, Degradation Resistance, and Cross-Seeding. Int. J. Mol. Sci. 2022;23(10):5513. doi: 10.3390/ijms23105513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Jiang B., Aliyan A., Cook N. P., Augustine A., Bhak G., Maldonado R., Smith McWilliams A. D., Flores E. M., Mendez N., Shahnawaz M., Godoy F. J., Montenegro J., Moreno-Gonzalez I., Martí A. A.. Monitoring the Formation of Amyloid Oligomers Using Photoluminescence Anisotropy. J. Am. Chem. Soc. 2019;141(39):15605–15610. doi: 10.1021/jacs.9b06966. [DOI] [PubMed] [Google Scholar]
  32. Yu H.-j., Zhao W., Xie M., Li X., Sun M., He J., Wang L., Yu L.. Real-Time Monitoring of Self-Aggregation of β-Amyloid by a Fluorescent Probe Based on Ruthenium Complex. Anal. Chem. 2020;92(4):2953–2960. doi: 10.1021/acs.analchem.9b03566. [DOI] [PubMed] [Google Scholar]
  33. Klunk W. E., Pettegrew J. W., Abraham D. J.. Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. J. Histochem. Cytochem. 1989;37(8):1273–1281. doi: 10.1177/37.8.2666510. [DOI] [PubMed] [Google Scholar]
  34. Krebs M. R., Bromley E. H., Donald A. M.. The binding of thioflavin-T to amyloid fibrils: localisation and implications. J. Struct. Biol. 2005;149(1):30–37. doi: 10.1016/j.jsb.2004.08.002. [DOI] [PubMed] [Google Scholar]
  35. LeVine H.. 3rd, Quantification of beta-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 1999;309:274–284. doi: 10.1016/S0076-6879(99)09020-5. [DOI] [PubMed] [Google Scholar]
  36. Zhang S., Guaglianone G., Morris M. A., Yoo S., Howitz W. J., Xing L., Zheng J. G., Jusuf H., Huizar G., Lin J., Kreutzer A. G., Nowick J. S.. Expression of N-Terminal Cysteine Aβ(42) and Conjugation to Generate Fluorescent and Biotinylated Aβ(42) Biochemistry. 2021;60(15):1191–1200. doi: 10.1021/acs.biochem.1c00105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Shimogawa M., Petersson E. J.. New strategies for fluorescently labeling proteins in the study of amyloids. Curr. Opin. Chem. Biol. 2021;64:57–66. doi: 10.1016/j.cbpa.2021.04.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Jungbauer L. M., Yu C., Laxton K. J., LaDu M. J.. Preparation of fluorescently-labeled amyloid-beta peptide assemblies: the effect of fluorophore conjugation on structure and function. J. Mol. Recogn. 2009;22(5):403–413. doi: 10.1002/jmr.948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Thacker D., Bless M., Barghouth M., Zhang E., Linse S.. A Palette of Fluorescent Aβ42 Peptides Labelled at a Range of Surface-Exposed Sites. Int. J. Mol. Sci. 2022;23(3):1655. doi: 10.3390/ijms23031655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Zheng Y., Xu L., Yang J., Peng X., Wang H., Yu N., Hua Y., Zhao J., He J., Hong T.. The effects of fluorescent labels on Aβ(42) aggregation detected by fluorescence correlation spectroscopy. Biopolymers. 2018;109(11):e23237. doi: 10.1002/bip.23237. [DOI] [PubMed] [Google Scholar]
  41. Seravalli J., Gu W., Tam A., Strauss E., Begley T. P., Cramer S. P., Ragsdale S. W.. Functional copper at the acetyl-CoA synthase active site. Proc. Natl. Acad. Sci. U. S. A. 2003;100(7):3689–3694. doi: 10.1073/pnas.0436720100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Darnault C., Volbeda A., Kim E. J., Legrand P., Vernède X., Lindahl P. A., Fontecilla-Camps J. C.. Ni-Zn-[Fe4-S4] and Ni-Ni-[Fe4-S4] clusters in closed and open subunits of acetyl-CoA synthase/carbon monoxide dehydrogenase. Nat. Struct. Biol. 2003;10(4):271–279. doi: 10.1038/nsb912. [DOI] [PubMed] [Google Scholar]
  43. Svetlitchnyi V., Dobbek H., Meyer-Klaucke W., Meins T., Thiele B., Römer P., Huber R., Meyer O.. A functional Ni-Ni-[4Fe-4S] cluster in the monomeric acetyl-CoA synthase from Carboxydothermus hydrogenoformans. Proc. Natl. Acad. Sci. U. S. A. 2004;101(2):446–451. doi: 10.1073/pnas.0304262101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Golden M., Darensbourg M., Irwin J., Frost B.. N,N′-Bis­(Mercaptoethyl)-1,4-Diazacycloheptane (H2BME-DACH) and its Nickel Complex: A Model for Bioinorganic Chemistry. Inorg. Synth. 2014;36:231–240. doi: 10.1002/9781118744994.ch43. [DOI] [Google Scholar]
  45. Golden M. L., Rampersad M. V., Reibenspies J. H., Darensbourg M. Y.. Capture of Ni­(II), Cu­(I) and Z­(II) by thiolate sulfurs of an N2S2Ni complex: a role for a metallothiolate ligand in the acetyl-coenzyme A synthase active site. Chem. Commun. 2003;15:1824–1825. doi: 10.1039/B304884P. [DOI] [PubMed] [Google Scholar]
  46. Schilling K., Ujueta F., Gao S., Anderson W. A., Escolar E., Mon A., Navas-Acien A., Lamas G. A.. Pharmacokinetics of metal excretion following different doses of sodium EDTA infusion. Metallomics. 2025;17(5):mfaf010. doi: 10.1093/mtomcs/mfaf010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Smee J. J., Miller M. L., Grapperhaus C. A., Reibenspies J. H., Darensbourg M. Y.. Subtle Bite-Angle Influences on N2S2Ni Complexes. Inorg. Chem. 2001;40(14):3601–3605. doi: 10.1021/ic0008619. [DOI] [PubMed] [Google Scholar]
  48. Rezaei-Ghaleh N., Giller K., Becker S., Zweckstetter M.. Effect of zinc binding on β-amyloid structure and dynamics: implications for Aβ aggregation. Biophys. J. 2011;101(5):1202–1211. doi: 10.1016/j.bpj.2011.06.062. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Wang Y., Clark T. B., Goodson T. III. Two-Photon and Time-Resolved Fluorescence Conformational Studies of Aggregation in Amyloid Peptides. J. Phys. Chem. B. 2010;114(20):7112–7120. doi: 10.1021/jp101496y. [DOI] [PubMed] [Google Scholar]
  50. Wang Y. C. T. B., Goodson T.. Two-Photon and Time-Resolved Fluorescence Conformational Studies of Aggregation in Amyloid Peptides. J. Phys. Chem. B. 2010;114:7112. doi: 10.1021/jp101496y. [DOI] [PubMed] [Google Scholar]
  51. Abelein A., Ciofi-Baffoni S., Mörman C., Kumar R., Giachetti A., Piccioli M., Biverstål H.. Molecular Structure of Cu­(II)-Bound Amyloid-β Monomer Implicated in Inhibition of Peptide Self-Assembly in Alzheimer’s Disease. JACS Au. 2022;2(11):2571–2584. doi: 10.1021/jacsau.2c00438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Atwood C. S., Moir R. D., Huang X., Scarpa R. C., Bacarra N. M. E., Romano D. M., Hartshorn M. A., Tanzi R. E., Bush A. I.. Dramatic Aggregation of Alzheimer Aβ by Cu­(II) Is Induced by Conditions Representing Physiological Acidosis. J. Biol. Chem. 1998;273(21):12817–12826. doi: 10.1074/jbc.273.21.12817. [DOI] [PubMed] [Google Scholar]
  53. Curtain C. C., Ali F., Volitakis I., Cherny R. A., Norton R. S., Beyreuther K., Barrow C. J., Masters C. L., Bush A. I., Barnham K. J.. Alzheimer’s Disease Amyloid-β Binds Copper and Zinc to Generate an Allosterically Ordered Membrane-penetrating Structure Containing Superoxide Dismutase-like Subunits. J. Biol. Chem. 2001;276(23):20466–20473. doi: 10.1074/jbc.M100175200. [DOI] [PubMed] [Google Scholar]
  54. Sunda A. P., Sharma A. K.. Molecular Insights into Cu/Zn Metal Response to the Amyloid β-Peptide (1–42) ACS Phys. Chem. Au. 2024;4(1):57–66. doi: 10.1021/acsphyschemau.3c00041. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Abelein A.. Metal Binding of Alzheimer’s Amyloid-β and Its Effect on Peptide Self-Assembly. Acc. Chem. Res. 2023;56(19):2653–2663. doi: 10.1021/acs.accounts.3c00370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Syme C. D., Nadal R. C., Rigby S. E. J., Viles J. H.. Copper Binding to the Amyloid-β (Aβ) Peptide Associated with Alzheimer’s Disease: folding, coordination geometry, ph dependence, stoichiometry, and affinity of aβ-(1–28): insights from a range of complementary spectroscopic techniques. J. Biol. Chem. 2004;279(18):18169–18177. doi: 10.1074/jbc.M313572200. [DOI] [PubMed] [Google Scholar]
  57. Bin Y., Chen S., Xiang J.. pH-dependent kinetics of copper ions binding to amyloid-β peptide. J. Inorg. Biochem. 2013;119:21–27. doi: 10.1016/j.jinorgbio.2012.10.013. [DOI] [PubMed] [Google Scholar]
  58. Liu B., Moloney A., Meehan S., Morris K., Thomas S. E., Serpell L. C., Hider R., Marciniak S. J., Lomas D. A., Crowther D. C.. Iron promotes the toxicity of amyloid beta peptide by impeding its ordered aggregation. J. Biol. Chem. 2011;286(6):4248–4256. doi: 10.1074/jbc.M110.158980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Alies B., Conte-Daban A., Sayen S., Collin F., Kieffer I., Guillon E., Faller P., Hureau C.. Zinc­(II) Binding Site to the Amyloid-β Peptide: Insights from Spectroscopic Studies with a Wide Series of Modified Peptides. Inorg. Chem. 2016;55(20):10499–10509. doi: 10.1021/acs.inorgchem.6b01733. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Tahmasebinia F., Emadi S.. Effect of metal chelators on the aggregation of beta-amyloid peptides in the presence of copper and iron. Biometals. 2017;30(2):285–293. doi: 10.1007/s10534-017-0005-2. [DOI] [PubMed] [Google Scholar]
  61. Kim, S. S. ; Yeo, D. ; Choi, T. G. . Metal Ions-Mediated Oxidative Stress in Alzheimer’s Disease and Chelation Therapy. In Reactive Oxygen Species; Ahmad, R. , Ed.; IntechOpen: Rijeka, 2021. [Google Scholar]
  62. Liu X., Millero F. J.. The solubility of iron hydroxide in sodium chloride solutions. Geochim. Cosmochim. Acta. 1999;63(19):3487–3497. doi: 10.1016/S0016-7037(99)00270-7. [DOI] [Google Scholar]
  63. Osterloh F., Saak W., Haase D., Pohl S.. Synthesis, X-ray structure and electrochemical characterisation of a binuclear thiolate bridged Ni–Fe–nitrosyl complex, related to the active site of NiFe hydrogenase. Chem. Commun. 1997;(10):979–980. doi: 10.1039/a700884h. [DOI] [Google Scholar]
  64. Lai C.-H., Reibenspies J. H., Darensbourg M. Y.. Thiolate Bridged Nickel–Iron Complexes Containing both Iron(0) and Iron­(II) Carbonyls. Angew. Chem., Int. Ed. Engl. 1996;35(20):2390–2393. doi: 10.1002/anie.199623901. [DOI] [Google Scholar]
  65. Li Z., Ohki Y., Tatsumi K.. Dithiolato-Bridged Dinuclear Iron–Nickel Complexes [Fe­(CO)­2­(CN)­2­(μ-SCH2CH2CH2S)­Ni­(S2CNR2)]- Modeling the Active Site of [NiFe] Hydrogenase. J. Am. Chem. Soc. 2005;127(25):8950–8951. doi: 10.1021/ja051590+. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

ao5c11345_si_001.pdf (1.9MB, pdf)

Articles from ACS Omega are provided here courtesy of American Chemical Society

RESOURCES